Alexander Cumbo - Net Worth and Insider Trading

Alexander Cumbo Net Worth

The estimated net worth of Alexander Cumbo is at least $639,189 dollars as of 2024-11-08. Alexander Cumbo is the EVP, Chief Commercial Officer of Sarepta Therapeutics Inc and owns about 5,308 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $639,189. Details can be seen in Alexander Cumbo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexander Cumbo has not made any transactions after 2019-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alexander Cumbo

To

Alexander Cumbo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alexander Cumbo owns 4 companies in total, including Ra Pharmaceuticals Inc (RARX) , Sarepta Therapeutics Inc (SRPT) , and Verve Therapeutics Inc (VERV) among others .

Click here to see the complete history of Alexander Cumbo’s form 4 insider trades.

Insider Ownership Summary of Alexander Cumbo

Ticker Comapny Transaction Date Type of Owner
RARX Ra Pharmaceuticals Inc 2020-04-02 director
SRPT Sarepta Therapeutics Inc 2019-12-13 VP & Head of Commercial
VERV Verve Therapeutics Inc 2022-06-09 director
LIMIT LIMIT 2022-12-02 director & President and CEO

Alexander Cumbo Latest Holdings Summary

Alexander Cumbo currently owns a total of 1 stock. Alexander Cumbo owns 5,308 shares of Sarepta Therapeutics Inc (SRPT) as of December 13, 2019, with a value of $639,189.

Latest Holdings of Alexander Cumbo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SRPT Sarepta Therapeutics Inc 2019-12-13 5,308 120.42 639,189

Holding Weightings of Alexander Cumbo


Alexander Cumbo Form 4 Trading Tracker

According to the SEC Form 4 filings, Alexander Cumbo has made a total of 1 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 42,000 shares on December 13, 2019, which brought Alexander Cumbo around $5 Million.

Insider Trading History of Alexander Cumbo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alexander Cumbo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Alexander Cumbo Ownership Network

Ownership Network List of Alexander Cumbo

No Data

Ownership Network Relation of Alexander Cumbo

Insider Network Chart

Alexander Cumbo Owned Company Details

What does Ra Pharmaceuticals Inc do?

Who are the key executives at Ra Pharmaceuticals Inc?

Alexander Cumbo is the director of Ra Pharmaceuticals Inc. Other key executives at Ra Pharmaceuticals Inc include Executive VP and CFO David Charles Lubner , director & 10 percent owner Rajeev M. Shah , and 10 percent owner New Enterprise Associates 13 Lp .

Ra Pharmaceuticals Inc (RARX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ra Pharmaceuticals Inc (RARX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ra Pharmaceuticals Inc (RARX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ra Pharmaceuticals Inc (RARX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ra Pharmaceuticals Inc Insider Transactions

No Available Data

Alexander Cumbo Mailing Address

Above is the net worth, insider trading, and ownership report for Alexander Cumbo. You might contact Alexander Cumbo via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.